Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare primary thymic carcinoma, characterized by the presence of keratinizing or non-keratinizing malignant squamous cells. Approximately 10-20% of cases occur in combination with thymoma. The prognosis depends on the tumor stage and the degree of cellular differentiation.
Biomarker and diagnostic research for thymus squamous cell carcinoma has been reported in the published literature.
No clinical trials have been registered for thymus squamous cell carcinoma.
49 publications have been identified in PubMed for thymus squamous cell carcinoma. Research spans Case Report / Case Series (51%), Diagnostic / Biomarker (16%), and Basic Science / Preclinical (10%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 25 | 51% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 5:35 AM UTC
Testing and diagnosis research
8 |
16% |
Laboratory research | 5 | 10% |
Research summaries | 4 | 8% |
New treatment approaches | 4 | 8% |
Clinical study results | 2 | 4% |
Disease patterns and progression | 1 | 2% |
Shen Z (2026). [PMID: 41512303](https://pubmed.ncbi.nlm.nih.gov/41512303/). *European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery*. [Diagnostic / Biomarker]
Cui M (2026). [PMID: 41789110](https://pubmed.ncbi.nlm.nih.gov/41789110/). *Frontiers in immunology*. [Gene Therapy / Novel Therapeutics]
Huang XX (2026). [PMID: 42096962](https://pubmed.ncbi.nlm.nih.gov/42096962/). *Int Immunopharmacol*. [Review / Meta-Analysis]
Deng J (2026). [PMID: 41678786](https://pubmed.ncbi.nlm.nih.gov/41678786/). *Clinical nuclear medicine*. [Diagnostic / Biomarker]
Yu L (2026). [PMID: 41974931](https://pubmed.ncbi.nlm.nih.gov/41974931/). *Virchows Arch*. [Case Report / Case Series]
Xu Y (2026). [PMID: 41762038](https://pubmed.ncbi.nlm.nih.gov/41762038/). *Cutaneous and ocular toxicology*. [Basic Science / Preclinical]
Tokuda R (2026). [PMID: 41669790](https://pubmed.ncbi.nlm.nih.gov/41669790/). *Interdisciplinary cardiovascular and thoracic surgery*. [Case Report / Case Series]
Seki S (2026). [PMID: 41906068](https://pubmed.ncbi.nlm.nih.gov/41906068/). *Pediatr Dermatol*. [Diagnostic / Biomarker]
Luo Y (2026). [PMID: 41668904](https://pubmed.ncbi.nlm.nih.gov/41668904/). *Gland surgery*. [Case Report / Case Series]
Zhang QX (2026). [PMID: 41836409](https://pubmed.ncbi.nlm.nih.gov/41836409/). *Frontiers in immunology*. [Case Report / Case Series]